Gene: S100B

6285
NEF|S100|S100-B|S100beta
S100 calcium binding protein B
protein-coding
21q22.3
Ensembl:ENSG00000160307 MIM:176990 Vega:OTTHUMG00000090715 UniprotKB:P04271
NC_000021.9
PubMed
OD|ND|AD
9   
NA (AD)  NA (ND)   (Frontal_Cortex)
3.636e-2 (AD)  5.305e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
PLEKHB10.91
TSC22D40.903
NDRG20.887
MARCKSL10.883
GCSH0.866
CRYL10.865
CSRP10.862
HADHB0.858
ACAA20.849
PTGDS0.846

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
OR4F29-0.595
OR4F5-0.561
KCNH5-0.458
HRH2-0.448
KLHL38-0.443
KCNH1-0.439
OPRD1-0.43
GDF7-0.429
LRRK1-0.429
PROKR2-0.428

Drugs/Compounds

ID Drug Name Drug Type CAS Num Status Role
DB00768OlopatadineSmall Molecule113806-05-6ApprovedTarget
DB01373CalciumSmall Molecule7440-70-2Approved|NutraceuticalTarget
DB04464N-FormylmethionineSmall MoleculeExperimentalTarget
DB05343Arundic acidSmall Molecule185517-21-9InvestigationalTarget
DB06941(Z)-2-[2-(4-methylpiperazin-1-yl)benzyl]diazenecarbothioamideSmall Molecule-ExperimentalTarget
DB070042-[(5-hex-1-yn-1-ylfuran-2-yl)carbonyl]-N-methylhydrazinecarbothioamideSmall MoleculeExperimentalTarget
DB11093Calcium CitrateSmall Molecule813-94-5ApprovedTarget
DB11348Calcium PhosphateSmall Molecule10103-46-5ApprovedTarget
ID Drug Name Action PubMed
C0297902,2',3',4,4',5-hexachlorobiphenyl"2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of S100B protein"21673325
C0939732-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Ammonia results in increased secretion of S100B protein]23284918
C5071302-(8-quinolinoxy)propionic acid2-(8-quinolinoxy)propionic acid inhibits the reaction [S100B protein results in increased expression of NOX2 mRNA]17327432
C4340033-(4-methylphenylsulfonyl)-2-propenenitrile3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [S100B protein results in increased degradation of NFKBIA protein]17327432
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100B mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100B mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100B mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100B mRNA"27188386
C5490664-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine"4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [S100B protein results in increased expression of AGER protein]"23541064
C5490664-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine"4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [S100B protein results in increased expression of BACE1 protein]"23541064
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100B mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100B mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100B mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100B mRNA"27188386
D000082AcetaminophenAcetaminophen results in decreased expression of S100B mRNA26690555
D000157AconitineABCB1A gene mutant form promotes the reaction [Aconitine results in increased expression of S100B protein]28193520
D000157AconitineAconitine results in increased expression of S100B protein28193520
D000535AluminumAluminum results in increased expression of S100B protein16545059
D000535AluminumVitamin E inhibits the reaction [Aluminum results in increased expression of S100B protein]16545059
D000641Ammonia2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Ammonia results in increased secretion of S100B protein]23284918
D000641AmmoniaAmmonia results in increased secretion of S100B protein23284918|2388015
D000641Ammonia[Furosemide results in decreased activity of SLC12A2 protein] affects the reaction [Thioctic Acid inhibits the reaction [Ammonia results in increased secretion of S100B protein]]23880158
D000641Ammonia[Furosemide results in decreased activity of SLC12A2 protein] inhibits the reaction [Ammonia results in increased secretion of S100B protein]23880158
D000641AmmoniaN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Ammonia results in increased secretion of S100B protein]23284918
D000641Ammoniaresveratrol inhibits the reaction [Ammonia results in increased secretion of S100B protein]23284918
D000641AmmoniaThioctic Acid inhibits the reaction [Ammonia results in increased secretion of S100B protein]23880158
D000643Ammonium ChlorideAmmonium Chloride affects the expression of S100B mRNA16483693
D000643Ammonium ChlorideAmmonium Chloride results in decreased expression of S100B protein16483693
C006632arsenic trioxidearsenic trioxide results in increased expression of S100B mRNA20458559
D001205Ascorbic AcidAscorbic Acid inhibits the reaction [cupric chloride promotes the reaction [S100B protein binds to S100B protein]]10666291
D001205Ascorbic AcidAscorbic Acid results in increased expression of S100B mRNA15372504
D016589AstemizoleAstemizole results in decreased expression of S100B mRNA20221588
D001280AtrazineAtrazine results in decreased expression of S100B mRNA25929836
C547126AZM551248AZM551248 results in decreased expression of S100B mRNA22323515
C480180beta-1,3-D-glucan"beta-1,3-D-glucan results in increased expression of S100B protein"28117141
D004958EstradiolEstradiol results in increased expression of S100B mRNA19484750
C095105bexarotenebexarotene results in decreased expression of S100B mRNA16648578
C006780bisphenol A[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of S100B mRNA28628672
C006780bisphenol Abisphenol A affects the expression of S100B mRNA25181051
C000611646bisphenol F[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of S100B mRNA28628672
D002065BuspironeS100B results in decreased susceptibility to Buspirone12888777
D002065BuspironeBuspirone results in increased expression of S100B mRNA12480124
D019256Cadmium ChlorideCadmium Chloride results in decreased methylation of S100B promoter22457795
C055494caffeic acid phenethyl estercaffeic acid phenethyl ester results in increased expression of S100B protein20836997
C055494caffeic acid phenethyl esterNGFR protein affects the susceptibility to [caffeic acid phenethyl ester results in increased expression of S100B protein]20836997
D002211CapsaicinCapsaicin results in increased expression of S100B protein17635592
D002235CarbofuranCarbofuran results in increased expression of S100B mRNA28982980
D002392CatechinCatechin inhibits the reaction [S100B protein results in increased abundance of Reactive Oxygen Species]17103373
D002392CatechinCatechin inhibits the reaction [S100B protein results in increased expression of CCL2 mRNA]17103373
D002392CatechinCatechin inhibits the reaction [S100B protein results in increased expression of CXCL10 mRNA]17103373
D002392CatechinCatechin inhibits the reaction [S100B protein results in increased expression of IL1B mRNA]17103373
D002392CatechinCatechin inhibits the reaction [S100B protein results in increased expression of ITGB2 mRNA]17103373
D002392CatechinCatechin inhibits the reaction [S100B protein results in increased expression of NCF1 protein]17103373
D002392CatechinCatechin inhibits the reaction [S100B protein results in increased expression of PECAM1 mRNA]17103373
D002392CatechinCatechin inhibits the reaction [S100B protein results in increased expression of PTGS2 mRNA]17103373
D002392CatechinCatechin inhibits the reaction [S100B protein results in increased expression of TNF mRNA]17103373
D004390ChlorpyrifosChlorpyrifos results in increased expression of S100B mRNA21356183
D004390Chlorpyrifos[Copper co-treated with Chlorpyrifos] results in increased expression of S100B mRNA21356183
C043561chrysinchrysin inhibits the reaction [Oxidopamine results in increased expression of S100B protein]29054324
D003035Cobalt[tungsten carbide co-treated with Cobalt] results in decreased expression of S100B mRNA18078969
D003042CocaineCocaine affects the expression of S100B protein8041492
D003042Cocaineipsapirone inhibits the reaction [Cocaine affects the expression of S100B protein]8041492
D003300Copper[Copper co-treated with Chlorpyrifos] results in increased expression of S100B mRNA21356183
D003300CopperCopper results in increased expression of S100B mRNA21356183
C029892cupric chlorideAscorbic Acid inhibits the reaction [cupric chloride promotes the reaction [S100B protein binds to S100B protein]]10666291
C029892cupric chloridecupric chloride promotes the reaction [S100B protein binds to S100B protein]10666291
D003513CycloheximideCycloheximide results in decreased expression of S100B mRNA19146868
D016572CyclosporineCyclosporine promotes the reaction [S100B protein results in increased activity of RELA protein]10463953
D016572CyclosporineCyclosporine results in increased activity of S100B protein10463953
C017160cypermethrincypermethrin promotes the reaction [S100B protein results in increased activity of RELA protein]10463953
C017160cypermethrincypermethrin results in increased activity of S100B protein10463953
D013759DronabinolDronabinol results in increased expression of S100B mRNA21955143
D003907DexamethasoneDexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of S100B mRNA]27941970
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of S100B mRNA28628672
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of S100B mRNA28628672
D003976DiazinonDiazinon affects the expression of S100B mRNA22546817
C016366dibenzothiophenedibenzothiophene results in decreased expression of S100B mRNA23656968
D003993Dibutyl PhthalateDibutyl Phthalate results in decreased expression of S100B mRNA21266533
D002117CalcitriolCalcitriol results in increased expression of S100B mRNA26485663
D004117DimethoateDimethoate results in increased expression of S100B mRNA21941777
D004117DimethoateDimethoate results in increased expression of S100B protein21941777
D0198131,2-Dimethylhydrazine"1,2-Dimethylhydrazine results in decreased expression of S100B mRNA"27840820
D0198131,2-Dimethylhydrazine"APC protein affects the reaction [1,2-Dimethylhydrazine results in decreased expression of S100B mRNA]"27840820
D0198131,2-Dimethylhydrazine"[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of S100B mRNA"27840820
D004137DinitrochlorobenzeneDinitrochlorobenzene results in decreased expression of S100B mRNA17374397
C007517diphenyleneiodoniumdiphenyleneiodonium inhibits the reaction [S100B protein results in increased expression of NOX2 mRNA]17327432
D004237DiuronDiuron results in decreased expression of S100B mRNA25152437
C118739entinostatentinostat results in increased expression of S100B mRNA27188386
D000431EthanolEthanol results in increased expression of S100B mRNA21955143
D005473FluoxetineFluoxetine results in increased expression of S100B mRNA20857517
D005473FluoxetineFluoxetine results in increased expression of S100B protein12960766
D005473FluoxetineS100B protein results in increased susceptibility to Fluoxetine22113448
D005473FluoxetineFluoxetine results in increased expression of S100B protein12960766
D005485FlutamideFlutamide results in decreased expression of S100B mRNA21126777
D005492Folic AcidFolic Acid results in decreased expression of S100B mRNA25006883
C069837fullerene C60fullerene C60 results in decreased expression of S100B mRNA19167457
D005665Furosemide[Furosemide results in decreased activity of SLC12A2 protein] affects the reaction [Thioctic Acid inhibits the reaction [Ammonia results in increased secretion of S100B protein]]23880158
D005665Furosemide[Furosemide results in decreased activity of SLC12A2 protein] inhibits the reaction [Ammonia results in increased secretion of S100B protein]23880158
C010974glyphosateglyphosate affects the expression of S100B protein28627408
D006493HeparinHeparin affects the expression of S100B protein12186470
D006861Hydrogen PeroxideHydrogen Peroxide results in decreased secretion of S100B protein18835240
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of S100B mRNA28628672
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of S100B mRNA28628672
C043077ipsapironeipsapirone inhibits the reaction [Cocaine affects the expression of S100B protein]8041492
C043077ipsapironeipsapirone results in increased secretion of S100B protein12480124
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of S100B mRNA28628672
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of S100B mRNA28628672
D007649KetamineKetamine results in increased expression of S100B mRNA20080153
C008261lead acetatelead acetate results in increased expression of S100B protein17047031
C485003LR-90LR-90 inhibits the reaction [S100B protein affects the localization of RELA protein]17327432
C485003LR-90LR-90 inhibits the reaction [S100B protein results in increased degradation of NFKBIA protein]17327432
C485003LR-90LR-90 inhibits the reaction [S100B protein results in increased expression of AGER mRNA]17327432
C485003LR-90LR-90 inhibits the reaction [S100B protein results in increased expression of CCL2 mRNA]17327432
C485003LR-90LR-90 inhibits the reaction [S100B protein results in increased expression of CCL2 protein]17327432
C485003LR-90LR-90 inhibits the reaction [S100B protein results in increased expression of CXCL10 mRNA]17327432
C485003LR-90LR-90 inhibits the reaction [S100B protein results in increased expression of NOX2 mRNA]17327432
C485003LR-90LR-90 inhibits the reaction [S100B protein results in increased expression of PTGS2 mRNA]17327432
C025340manganese chloridemanganese chloride results in increased expression of S100B mRNA15295902
C025340manganese chloridemanganese chloride results in increased expression of S100B protein15295902
D015122MercaptopurineMercaptopurine results in increased expression of S100B mRNA23358152
C004925methylmercuric chloridemethylmercuric chloride results in increased expression of S100B protein21783483
D008767Methylmercury CompoundsMethylmercury Compounds affects the expression of S100B mRNA26558463
D008767Methylmercury CompoundsMethylmercury Compounds results in increased expression of S100B mRNA16966085
D008767Methylmercury CompoundsMethylmercury Compounds results in increased expression of S100B protein15288508
C060893MK-886MK-886 inhibits the reaction [pirinixic acid affects the expression of S100B protein]16863991
C517880monascinmonascin inhibits the reaction [S100B protein results in decreased expression of GCLM mRNA]23331247
C517880monascinmonascin inhibits the reaction [S100B protein results in decreased expression of HMOX1 mRNA]23331247
C517880monascinmonascin inhibits the reaction [S100B protein results in decreased expression of NFE2L2 protein]23331247
C517880monascinmonascin inhibits the reaction [S100B protein results in increased expression of and affects the localization of NCF1 protein]23331247
C517880monascinmonascin inhibits the reaction [S100B protein results in increased expression of IL1B protein]23331247
C517880monascinmonascin inhibits the reaction [S100B protein results in increased expression of KEAP1 protein]23331247
C517880monascinmonascin inhibits the reaction [S100B protein results in increased expression of TNF protein]23331247
C517880monascinmonascin promotes the reaction [S100B protein affects the localization of NFE2L2 protein]23331247
C517880monascinNFE2L2 mutant form inhibits the reaction [monascin inhibits the reaction [S100B protein results in decreased expression of GCLM mRNA]]23331247
C517880monascinNFE2L2 mutant form inhibits the reaction [monascin inhibits the reaction [S100B protein results in decreased expression of HMOX1 mRNA]]23331247
C517880monascinNFE2L2 mutant form inhibits the reaction [monascin inhibits the reaction [S100B protein results in increased expression of IL1B protein]]23331247
C517880monascinNFE2L2 mutant form inhibits the reaction [monascin inhibits the reaction [S100B protein results in increased expression of TNF protein]]23331247
D009020MorphineMorphine results in decreased expression of S100B mRNA21955143
C523799MRK 003MRK 003 results in decreased expression of S100B mRNA21169257
C063509N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamideN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Ammonia results in increased secretion of S100B protein]23284918
D037742Nanotubes, Carbon"Nanotubes, Carbon results in decreased expression of S100B mRNA"25554681
C029938nickel sulfatenickel sulfate results in decreased expression of S100B mRNA17374397
D009538NicotineNicotine results in decreased expression of S100B mRNA21955143
D009569Nitric Oxide[S100B protein binds to S100B protein] which results in increased abundance of Nitric Oxide10666291
D009569Nitric Oxide[S100B protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide16376947
D009569Nitric Oxide[S100B protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide16376947
D009599NitroprussideNitroprusside results in increased secretion of S100B protein23284918
D009599Nitroprussideresveratrol inhibits the reaction [Nitroprusside results in increased secretion of S100B protein]23284918
D009638NorepinephrineNorepinephrine results in increased expression of S100B mRNA9788975
D009638NorepinephrineNorepinephrine results in increased expression of S100B protein9788975
D009638NorepinephrineS100B protein affects the susceptibility to Norepinephrine9788975
D016627Oxidopaminechrysin inhibits the reaction [Oxidopamine results in increased expression of S100B protein]29054324
D016627OxidopamineOxidopamine results in increased expression of S100B protein29054324
D010081OxazoloneOxazolone results in decreased expression of S100B mRNA17374397
C496932panobinostat"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100B mRNA"27188386
C496932panobinostatpanobinostat results in increased expression of S100B mRNA26272509
D010269ParaquatParaquat results in increased expression of S100B mRNA25314302
D010269ParaquatParaquat affects the expression of S100B mRNA16854511
D010269ParaquatParaquat results in increased expression of S100B protein24521700
C101814perfluoro-n-undecanoic acidperfluoro-n-undecanoic acid results in increased expression of S100B mRNA23602845
C076994perfluorooctane sulfonic acidperfluorooctane sulfonic acid results in increased expression of S100B protein20937303
D010656PhenylephrinePhenylephrine results in increased expression of S100B mRNA15652358
D010656PhenylephrineS100A6 protein inhibits the reaction [Phenylephrine results in increased expression of S100B mRNA]15652358
D010656PhenylephrineS100B protein inhibits the reaction [Phenylephrine results in increased expression of ACTA1 mRNA]15652358
D010656PhenylephrineS100B protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]15652358
D010862PilocarpinePilocarpine results in increased expression of S100B protein18226170
C004479pimagedinepimagedine inhibits the reaction [Streptozocin results in decreased expression of S100B protein]19494442
C004479pimagedinepimagedine inhibits the reaction [Streptozocin results in increased expression of S100B protein]19494442
C006253pirinixic acidMK-886 inhibits the reaction [pirinixic acid affects the expression of S100B protein]16863991
C006253pirinixic acidpirinixic acid affects the expression of S100B protein16863991
D028321Plant PreparationsPlant Preparations results in increased expression of S100B mRNA26945725
D011441PropylthiouracilPropylthiouracil results in decreased expression of S100B mRNA24780913
C005581protocatechualdehydeprotocatechualdehyde inhibits the reaction [S100B protein results in increased expression of AGER mRNA]17597607
C005581protocatechualdehydeprotocatechualdehyde inhibits the reaction [S100B protein results in increased expression of AGER protein]17597607
C005581protocatechualdehydeprotocatechualdehyde inhibits the reaction [S100B protein results in increased expression of TGFB1 mRNA]17597607
C005581protocatechualdehydeprotocatechualdehyde inhibits the reaction [S100B protein results in increased expression of TGFB1 protein]17597607
C005581protocatechualdehydeprotocatechualdehyde inhibits the reaction [S100B protein results in increased phosphorylation of and affects the localization of SMAD2 protein]17597607
C005581protocatechualdehydeprotocatechualdehyde inhibits the reaction [S100B protein results in increased phosphorylation of and affects the localization of SMAD3 protein]17597607
D011794QuercetinQuercetin inhibits the reaction [S100B protein results in increased abundance of Reactive Oxygen Species]17103373
D011794QuercetinQuercetin inhibits the reaction [S100B protein results in increased expression of CCL2 mRNA]17103373
D011794QuercetinQuercetin inhibits the reaction [S100B protein results in increased expression of CXCL10 mRNA]17103373
D011794QuercetinQuercetin inhibits the reaction [S100B protein results in increased expression of IL1B mRNA]17103373
D011794QuercetinQuercetin inhibits the reaction [S100B protein results in increased expression of ITGB2 mRNA]17103373
D011794QuercetinQuercetin inhibits the reaction [S100B protein results in increased expression of MAPK1 protein]17103373
D011794QuercetinQuercetin inhibits the reaction [S100B protein results in increased expression of MAPK3 protein]17103373
D011794QuercetinQuercetin inhibits the reaction [S100B protein results in increased expression of NCF1 protein]17103373
D011794QuercetinQuercetin inhibits the reaction [S100B protein results in increased expression of PECAM1 mRNA]17103373
D011794QuercetinQuercetin inhibits the reaction [S100B protein results in increased expression of PTGS2 mRNA]17103373
D011794QuercetinQuercetin inhibits the reaction [S100B protein results in increased expression of TNF mRNA]17103373
D011794QuercetinQuercetin inhibits the reaction [S100B protein results in increased phosphorylation of MAPK1 protein]17103373
D011794QuercetinQuercetin inhibits the reaction [S100B protein results in increased phosphorylation of MAPK3 protein]17103373
D017382Reactive Oxygen SpeciesCatechin inhibits the reaction [S100B protein results in increased abundance of Reactive Oxygen Species]17103373
D017382Reactive Oxygen SpeciesQuercetin inhibits the reaction [S100B protein results in increased abundance of Reactive Oxygen Species]17103373
D017382Reactive Oxygen SpeciesS100B protein results in increased abundance of Reactive Oxygen Species17103373
D017382Reactive Oxygen SpeciesS100B protein results in increased abundance of Reactive Oxygen Species16376947
D017382Reactive Oxygen SpeciesS100B protein results in increased abundance of Reactive Oxygen Species16376947
C059514resveratrolresveratrol inhibits the reaction [Ammonia results in increased secretion of S100B protein]23284918
C059514resveratrolresveratrol inhibits the reaction [Nitroprusside results in increased secretion of S100B protein]23284918
C059514resveratrolresveratrol results in increased expression of S100B protein16904623
C059514resveratrolresveratrol results in increased secretion of S100B protein17554623
D018967RisperidoneRisperidone results in increased secretion of S100B protein18421423
D012524SarinSarin results in decreased expression of S100B protein25842371
C093642SB 203580SB 203580 inhibits the reaction [S100B protein results in increased expression of NOS2 mRNA]16376947
C093642SB 203580SB 203580 inhibits the reaction [S100B protein results in increased expression of NOS2 protein]16376947
D012715Sesame OilSesame Oil results in increased expression of S100B mRNA29191790
D012838SilymarinNFE2L2 mutant form inhibits the reaction [Silymarin inhibits the reaction [S100B protein results in decreased expression of GCLM mRNA]]23331247
D012838SilymarinNFE2L2 mutant form inhibits the reaction [Silymarin inhibits the reaction [S100B protein results in decreased expression of HMOX1 mRNA]]23331247
D012838SilymarinSilymarin inhibits the reaction [S100B protein results in decreased expression of GCLM mRNA]23331247
D012838SilymarinSilymarin inhibits the reaction [S100B protein results in decreased expression of HMOX1 mRNA]23331247
D012838SilymarinSilymarin inhibits the reaction [S100B protein results in decreased expression of NFE2L2 protein]23331247
D012838SilymarinSilymarin inhibits the reaction [S100B protein results in increased expression of and affects the localization of NCF1 protein]23331247
D012838SilymarinSilymarin inhibits the reaction [S100B protein results in increased expression of IL1B protein]23331247
D012838SilymarinSilymarin inhibits the reaction [S100B protein results in increased expression of KEAP1 protein]23331247
D012838SilymarinSilymarin inhibits the reaction [S100B protein results in increased expression of TNF protein]23331247
D012838SilymarinSilymarin promotes the reaction [S100B protein affects the localization of NFE2L2 protein]23331247
D012999SomanSoman results in decreased expression of S100B mRNA19281266
D013311Streptozocinpimagedine inhibits the reaction [Streptozocin results in decreased expression of S100B protein]19494442
D013311Streptozocinpimagedine inhibits the reaction [Streptozocin results in increased expression of S100B protein]19494442
D013311StreptozocinStreptozocin results in decreased expression of S100B protein19494442|2095364
D013311StreptozocinStreptozocin results in increased expression of S100B protein19494442
D010042OuabainOuabain results in increased expression of S100B protein15581912
D016559TacrolimusTacrolimus promotes the reaction [S100B protein results in increased activity of RELA protein]10463953
D016559TacrolimusTacrolimus results in increased activity of S100B protein10463953
C020806tetrabromobisphenol Atetrabromobisphenol A results in decreased expression of S100B mRNA25172293
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of S100B mRNA17101203
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of S100B mRNA21296121
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of S100B mRNA24680724
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin promotes the reaction [AHR protein binds to S100B promoter]19654925
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of S100B mRNA22808131
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of S100B mRNA26232522
D013755Tetradecanoylphorbol AcetateTetradecanoylphorbol Acetate inhibits the reaction [Trientine inhibits the reaction [S100B protein results in increased expression of AGER protein]]23541064
D013755Tetradecanoylphorbol AcetateTetradecanoylphorbol Acetate inhibits the reaction [Trientine inhibits the reaction [S100B protein results in increased expression of BACE1 protein]]23541064
D008063Thioctic Acid[Furosemide results in decreased activity of SLC12A2 protein] affects the reaction [Thioctic Acid inhibits the reaction [Ammonia results in increased secretion of S100B protein]]23880158
D008063Thioctic AcidThioctic Acid inhibits the reaction [Ammonia results in increased secretion of S100B protein]23880158
C009495titanium dioxidetitanium dioxide affects the expression of S100B mRNA17656681
C009495titanium dioxidetitanium dioxide results in decreased expression of S100B mRNA23557971
D014107Tosyllysine Chloromethyl KetoneTosyllysine Chloromethyl Ketone inhibits the reaction [S100B protein results in increased expression of NOS2 mRNA]16376947
D014107Tosyllysine Chloromethyl KetoneTosyllysine Chloromethyl Ketone inhibits the reaction [S100B protein results in increased expression of NOS2 protein]16376947
C012589trichostatin A"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100B mRNA"27188386
C012589trichostatin Atrichostatin A results in increased expression of S100B mRNA24935251|2627250
D014266TrientineTetradecanoylphorbol Acetate inhibits the reaction [Trientine inhibits the reaction [S100B protein results in increased expression of AGER protein]]23541064
D014266TrientineTetradecanoylphorbol Acetate inhibits the reaction [Trientine inhibits the reaction [S100B protein results in increased expression of BACE1 protein]]23541064
D014266TrientineTrientine inhibits the reaction [S100B protein results in increased expression of AGER protein]23541064
D014266TrientineTrientine inhibits the reaction [S100B protein results in increased expression of BACE1 protein]23541064
C002802tungsten carbide[tungsten carbide co-treated with Cobalt] results in decreased expression of S100B mRNA18078969
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100B mRNA"27188386
D014635Valproic AcidValproic Acid affects the expression of S100B mRNA25979313
D014635Valproic AcidValproic Acid results in decreased methylation of S100B gene29154799
D014635Valproic AcidValproic Acid results in increased expression of S100B mRNA23179753|2438349
D014635Valproic AcidValproic Acid affects the expression of S100B mRNA17292431
C025643vinclozolinvinclozolin results in decreased expression of S100B mRNA23034163
D014810Vitamin EVitamin E inhibits the reaction [Aluminum results in increased expression of S100B protein]16545059
C111237vorinostat"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100B mRNA"27188386
C111237vorinostatvorinostat results in increased expression of S100B mRNA27188386
D015032ZincZinc binds to S100B protein17050004

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0005509calcium ion binding-NAS9519411  
GO:0005515protein binding-IPI3111527  10913138  16189514  17660747  17726019  20591429  
21516116  25416956  26496610  26871637  27107012  27107014  
GO:0008270zinc ion binding-ISS-  
GO:0042802identical protein binding-IPI10913138  17660747  25416956  26871637  27107012  
GO:0042803protein homodimerization activity-IDA10913138  
GO:0042803protein homodimerization activity-IPI9519411  
GO:0044548S100 protein binding-IPI9519411  10913138  
GO:0048156tau protein binding-ISS-  
GO:0048306calcium-dependent protein binding-IDA10913138  
GO:0050786RAGE receptor binding-IPI15033494  
GO ID GO Term Qualifier Evidence PubMed
GO:0007409axonogenesis-TAS8202493  
GO:0007417central nervous system development-TAS8202493  
GO:0007611learning or memory-ISS-  
GO:0007613memory-IEA-  
GO:0008283cell proliferation-TAS8202493  
GO:0008284positive regulation of cell proliferation-IEA-  
GO:0008360regulation of cell shape-IEA-  
GO:0031643positive regulation of myelination-IEA-  
GO:0043065positive regulation of apoptotic process-IEA-  
GO:0043123positive regulation of I-kappaB kinase/NF-kappaB signaling-IDA15033494  
GO:0045087innate immune response-TAS-  
GO:0048168regulation of neuronal synaptic plasticity-IEA-  
GO:0048708astrocyte differentiation-IEA-  
GO:0051384response to glucocorticoid-IEA-  
GO:0051597response to methylmercury-IEA-  
GO:0060291long-term synaptic potentiation-IEA-  
GO:0071456cellular response to hypoxia-IEA-  
GO:2001015negative regulation of skeletal muscle cell differentiation-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0001726ruffle-IDA10913138  
GO:0005576extracellular region-TAS-  
GO:0005615extracellular space-IEA-  
GO:0005634nucleus-IDA10913138  
GO:0005737cytoplasm-IDA10913138  
GO:0005737cytoplasm-ISS-  
GO:0043025neuronal cell body-IEA-  
GO:0048471perinuclear region of cytoplasm-IDA12118070  15033494  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence
R-HSA-1236394Signaling by ERBB4TAS
R-HSA-1251985Nuclear signaling by ERBB4TAS
R-HSA-1280215Cytokine Signaling in Immune systemTAS
R-HSA-1606322ZBP1(DAI) mediated induction of type I IFNsTAS
R-HSA-162582Signal TransductionTAS
R-HSA-166016Toll Like Receptor 4 (TLR4) CascadeTAS
R-HSA-166058MyD88:Mal cascade initiated on plasma membraneTAS
R-HSA-166166MyD88-independent TLR4 cascade TAS
R-HSA-168138Toll Like Receptor 9 (TLR9) CascadeTAS
R-HSA-168142Toll Like Receptor 10 (TLR10) CascadeTAS
R-HSA-168164Toll Like Receptor 3 (TLR3) CascadeTAS
R-HSA-168176Toll Like Receptor 5 (TLR5) CascadeTAS
R-HSA-168179Toll Like Receptor TLR1:TLR2 CascadeTAS
R-HSA-168181Toll Like Receptor 7/8 (TLR7/8) CascadeTAS
R-HSA-168188Toll Like Receptor TLR6:TLR2 CascadeTAS
R-HSA-168249Innate Immune SystemTAS
R-HSA-168249Innate Immune SystemIEA
R-HSA-168256Immune SystemTAS
R-HSA-168256Immune SystemIEA
R-HSA-168898Toll-Like Receptors CascadesTAS
R-HSA-168928DDX58/IFIH1-mediated induction of interferon-alpha/betaTAS
R-HSA-1810476RIP-mediated NFkB activation via ZBP1TAS
R-HSA-181438Toll Like Receptor 2 (TLR2) CascadeTAS
R-HSA-1834949Cytosolic sensors of pathogen-associated DNA TAS
R-HSA-3134963DEx/H-box helicases activate type I IFN and inflammatory cytokines production TAS
R-HSA-445989TAK1 activates NFkB by phosphorylation and activation of IKKs complexTAS
R-HSA-446652Interleukin-1 family signalingTAS
R-HSA-449147Signaling by InterleukinsTAS
R-HSA-879415Advanced glycosylation endproduct receptor signalingTAS
R-HSA-879415Advanced glycosylation endproduct receptor signalingIEA
R-HSA-9006934Signaling by Receptor Tyrosine KinasesTAS
R-HSA-9020702Interleukin-1 signalingTAS
R-HSA-933542TRAF6 mediated NF-kB activationTAS
R-HSA-937061TRIF(TICAM1)-mediated TLR4 signaling TAS
R-HSA-975138TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activationTAS
R-HSA-975155MyD88 dependent cascade initiated on endosomeTAS
R-HSA-975871MyD88 cascade initiated on plasma membraneTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
28117141Influence of exposure to coarse, fine and ultrafine urban particulate matter and their biological constituents on neural biomarkers in a randomized controlled crossover study. (2017 Apr)Liu LEnviron Int
21785943An exploration of the associations of pregnancy and perinatal features with cytokines and tryptophan/kynurenine metabolism in children with attention-deficit hyperactivity disorder (ADHD). (2011 Dec)Oades RDAtten Defic Hyperact Disord
20510426Increased serum S100B in never-medicated and medicated schizophrenic patients. (2010 Dec)Zhang XYJ Psychiatr Res
16687214Specific changes in levels of autoantibodies to glutamate and opiate receptors induced by morphine administration in rats. (2006 Jul 31)Granstrem ONeurosci Lett
29607329Prognostic Roles of mRNA Expression of S100 in Non-Small-Cell Lung Cancer. (2018)Liu YBiomed Res Int
28499411Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade. (2017 May 12)Gambichler TBMC Cancer
16631170A low chronic ethanol exposure induces morphological changes in the adolescent rat brain that are not fully recovered even after a long abstinence: an immunohistochemical study. (2006 Aug)Evrard SGExp Neurol
20593192S100B and homocysteine in the acute alcohol withdrawal syndrome. (2011 Mar)Wedekind DEur Arch Psychiatry Clin Neurosci
28418321S100A10 identified in a genome-wide gene x cannabis dependence interaction analysis of risky sexual behaviours. (2017 Jun)Polimanti RJ Psychiatry Neurosci